When both the liver and kidneys shut down, the body loses its two primary filtration systems at once. Waste products, toxins, and excess fluid accumulate rapidly, triggering a cascade of symptoms that affects nearly every other organ. Without treatment, the median survival for the most severe form of combined liver-kidney failure is roughly 11 days, with only a 25% chance of surviving past 30 days. Understanding what’s happening inside the body, and what it looks like from the outside, can help you prepare for what comes next.
How Liver Failure Pulls the Kidneys Down
The liver and kidneys don’t usually fail independently of each other. In most cases, the liver fails first and drags the kidneys along through a well-documented chain reaction called hepatorenal syndrome. Here’s the sequence: a failing liver causes blood vessels in the abdomen to widen dramatically, which pools blood in the gut and away from the rest of the body. The heart and nervous system detect this drop in circulating blood volume and respond by activating emergency systems, including stress hormones, adrenaline pathways, and a system that controls blood pressure through the kidneys.
The body’s fix, ironically, makes things worse. To compensate for the blood pooling in the abdomen, the kidneys’ own blood vessels clamp down hard. Less and less blood reaches the kidneys, and their filtering capacity drops. As the liver disease progresses, the heart also weakens, pushing even less blood to the kidneys. The result is a self-reinforcing spiral: the sicker the liver gets, the less blood the kidneys receive, and the faster they fail. In human studies, blocking blood flow through the liver’s main vein immediately reduces kidney blood flow by more than the drop in overall circulation would explain, suggesting a direct reflex connection between the two organs.
What Happens Inside the Body
The liver and kidneys together are responsible for clearing virtually all metabolic waste. When both go offline, two categories of toxins build up quickly.
The liver normally converts ammonia, a byproduct of protein digestion, into a harmless substance that leaves through urine. Without a working liver, ammonia floods the bloodstream. At blood levels above 150 to 200 micromoles per liter, ammonia crosses into the brain, where it causes swelling, disrupts the barrier that normally protects brain tissue, and interferes with the brain’s ability to regulate its own blood flow. This is what drives the confusion, disorientation, and eventual unconsciousness seen in late-stage liver failure.
The kidneys, meanwhile, are supposed to filter out urea, creatinine, potassium, acids, and dozens of other waste products. When they stop, these toxins accumulate in a condition called uremia. Bilirubin, the yellow pigment the liver processes, also builds up. Bilirubin levels above 12 mg/dL signal severe liver dysfunction. Critically ill patients whose bilirubin climbs above 30 mg/dL face significantly worse outcomes, and those with multiple failing organs, high lactate, and poor clotting function are least likely to recover.
Visible Signs and Symptoms
Combined liver-kidney failure produces a distinct set of changes that worsen over days to weeks. The most recognizable is jaundice: deep yellowing of the skin and the whites of the eyes as bilirubin accumulates. Fluid that the kidneys can no longer remove collects in the abdomen (ascites), sometimes holding liters of liquid that visibly distends the belly. The same fluid can accumulate around the lungs, causing shortness of breath and noisy breathing.
Urine output drops sharply or stops entirely. Swelling appears in the feet, ankles, and legs. Because the blood can no longer clot properly (the liver makes most clotting proteins), bruising and bleeding become common. The skin may itch intensely from toxin buildup.
Neurological changes follow a predictable path. Early on, there’s mild confusion, difficulty concentrating, and a reversal of the sleep-wake cycle. This progresses to obvious disorientation, slurred speech, and agitation. In advanced stages, the person becomes deeply drowsy, then unresponsive. Seizures can occur, particularly when ammonia levels are very high. A person with ammonia levels around 300 micromoles per liter will typically be in a deep coma.
How Doctors Try to Reverse It
The primary medical strategy targets the root problem: not enough blood reaching the kidneys. Doctors use medications that constrict the widened abdominal blood vessels, redirecting blood flow back to the central circulation and the kidneys. This is paired with intravenous albumin, a protein that helps hold fluid inside blood vessels rather than letting it leak into the abdomen and lungs.
In a large clinical trial published in the New England Journal of Medicine, this combination reversed kidney failure in about 32% of patients in the treatment group, compared to 17% who received a placebo. Among patients with active systemic inflammation, the treatment was even more effective, reversing kidney failure in 37% versus just 6%. Those whose kidneys responded to treatment had a median survival of 29 months, compared to 8 months for those who didn’t respond.
For fluid buildup, doctors drain the abdomen directly using a needle and catheter, sometimes removing several liters at a time. About 90% of patients with ascites respond to diuretics and fluid restriction initially, but as kidney function declines, these stop working. Fluid around the lungs can be drained in a similar procedure. In refractory cases, patients may need repeated drainage sessions or implanted ports for ongoing management.
When Transplant Becomes the Only Option
For many patients, the only path to long-term survival is a transplant. When both organs have failed, a simultaneous liver-kidney transplant may be necessary rather than replacing just one. The qualifying criteria are specific: patients generally need to have been on dialysis for at least six weeks, or have a kidney filtration rate below 25 to 30 mL per minute sustained over several weeks. Some guidelines recommend waiting 90 days on dialysis before listing for a dual transplant, to give the kidneys a fair chance to recover on their own once the liver is replaced.
Other qualifying factors include a kidney biopsy showing more than 30% permanent scarring, significant protein in the urine, or underlying conditions like diabetes and high blood pressure that make kidney recovery unlikely. The decision between a liver-only transplant (hoping the kidneys bounce back) and a combined transplant is one of the most difficult calls in transplant medicine.
Doctors use a scoring system called MELD-Na to prioritize who receives a liver transplant. It factors in bilirubin, creatinine (a marker of kidney function), blood clotting speed, and sodium levels. Creatinine carries one of the heaviest weights in the score, which means patients with combined liver-kidney failure are prioritized higher on the transplant list.
The Final Days
When treatment cannot reverse the decline and transplant isn’t possible, the body follows a recognizable pattern in its final days. Pain increases, including headaches and deep bone pain. Agitation and delirium give way to prolonged drowsiness and then unconsciousness. The person stops eating and eventually can only take small sips of fluid. Urine output may stop entirely. Breathing becomes labored and often noisy. Muscle cramps and itching from toxin buildup persist, and seizures remain a risk.
Becoming bed-bound, drinking less, and losing consciousness are a normal part of the dying process in this situation, not signs of a treatment failure or something that was missed. Palliative care during this stage focuses on managing pain, agitation, nausea, itching, and breathing difficulty to keep the person as comfortable as possible.